Drug:
Reaction: INJECTION SITE ERYTHEMA
20260101 - 20261231
No. 101 - 200
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 101 | 26538400 |
US |
62 | |
Injection site urticaria, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 102 | 26538712 |
US |
51 | 1 |
Rhinitis, Malaise, Pruritus, Scratch, Haemorrhage, Rash macular, Epistaxis, Injection site erythema, Rash pruritic, Pain, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 103 | 26538785 |
US |
9 | 2 |
Injection site swelling, Injection site erythema, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 104 | 26539306 |
|||
Injection site erythema, Injection site swelling, |
||||
TIRZEPATIDE, |
||||
| 105 | 26539423 |
US |
65 | 2 |
Injection site irritation, Injection site pain, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 106 | 26539517 |
US |
72 | 2 |
Injection site induration, Injection site erythema, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, PANTOPRAZOLE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LOPERAMIDE HYDROCHLORIDE, LOPERAMIDE HYDROCHLORIDE AND DIMETHICONE, |
||||
| 107 | 26539567 |
US |
73 | 2 |
Injection site pruritus, Injection site erythema, Injection site swelling, Dry eye, Paraesthesia, Eye pruritus, Product use in unapproved indication, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 108 | 26540172 |
US |
55 | 2 |
Injection site mass, Injection site erythema, Injection site discolouration, Injection site pruritus, |
||||
TIRZEPATIDE, |
||||
| 109 | 26540804 |
US |
23 | 2 |
Injection site swelling, Injection site erythema, Dermatitis atopic, |
||||
DUPILUMAB, DUPILUMAB, DUPILUMAB, DUPILUMAB, |
||||
| 110 | 26545984 |
29 | 2 | |
Injection site erythema, Injection site urticaria, |
||||
METHOTREXATE SODIUM, |
||||
| 111 | 26531455 |
EU |
79 | 1 |
Dermo-hypodermitis, Infusion site reaction, Impaired healing, Wound, Erythema, Ulcer, Injection site erythema, Injection site pruritus, Injection site swelling, |
||||
| 112 | 26531529 |
US |
66 | 2 |
Injection site erythema, Injection site haemorrhage, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 113 | 26531538 |
US |
2 | |
Platelet count increased, Arthritis, Pain in extremity, Bone pain, Back pain, Eye pruritus, Eye irritation, Gingival pain, Influenza like illness, Dizziness, Injection site erythema, |
||||
ROPEGINTERFERON ALFA-2B, |
||||
| 114 | 26531595 |
US |
2 | |
Injection site erythema, Injection site pruritus, Injection site hypersensitivity, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 115 | 26532017 |
US |
||
Injection site swelling, Injection site erythema, |
||||
ICATIBANT, |
||||
| 116 | 26532251 |
11 | ||
Injection site erythema, Product use issue, |
||||
OLEZARSEN SODIUM, HYDROXYZINE, MOMETASONE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, VENLAFAXINE, VENLAFAXINE HYDROCHLORIDE, SEMAGLUTIDE, |
||||
| 117 | 26532316 |
US |
63 | 2 |
Injection site rash, Injection site pruritus, Injection site erythema, Injection site bruising, Injection site swelling, |
||||
TIRZEPATIDE, |
||||
| 118 | 26532736 |
US |
||
Product use issue, Injection site erythema, Injection site pruritus, Injection site irritation, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 119 | 26533117 |
US |
74 | 2 |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 120 | 26533121 |
US |
63 | 2 |
Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, |
||||
| 121 | 26533331 |
US |
32 | 2 |
Injection site erythema, |
||||
DUPILUMAB, |
||||
| 122 | 26533488 |
US |
24 | 2 |
Food allergy, Pruritus, Injection site reaction, Injection site erythema, Injection site rash, Injection site inflammation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 123 | 26533491 |
US |
33 | 2 |
Injection site erythema, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 124 | 26533908 |
US |
41 | 2 |
Lipoatrophy, Injection site pruritus, Injection site nodule, Injection site urticaria, Skin discolouration, Rash macular, Skin disorder, Immediate post-injection reaction, Hyperaesthesia, Injection site pain, Injection site erythema, Stress, |
||||
GLATIRAMER ACETATE, |
||||
| 125 | 26534031 |
US |
67 | 2 |
Injection site erythema, Injection site swelling, Injection site pruritus, |
||||
TIRZEPATIDE, HYDROCHLOROTHIAZIDE, AMLODIPINE, LOSARTAN, |
||||
| 126 | 26534038 |
US |
36 | 1 |
Injection site swelling, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 127 | 26534494 |
US |
23 | 2 |
Injection site pain, Injection site erythema, Injection site swelling, Injection site pruritus, Injection site bruising, |
||||
DUPILUMAB, |
||||
| 128 | 26534751 |
US |
2 | |
Product use in unapproved indication, Injection site papule, Injection site erythema, Injection site pruritus, |
||||
ONABOTULINUMTOXINA, |
||||
| 129 | 26534783 |
US |
27 | 2 |
Injection site erythema, Injection site inflammation, |
||||
DUPILUMAB, |
||||
| 130 | 26535195 |
US |
67 | 1 |
Injection site erythema, Injection site pain, Injection site pruritus, Injection site swelling, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 131 | 26537479 |
27 | 2 | |
Injection site erythema, Skin warm, Contusion, |
||||
TRALOKINUMAB-LDRM, TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, |
||||
| 132 | 26526852 |
US |
69 | |
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 133 | 26527297 |
US |
67 | 2 |
Injection site erythema, Injection site urticaria, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, INSULIN DEGLUDEC, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, |
||||
| 134 | 26528009 |
US |
75 | 2 |
Injection site pruritus, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 135 | 26528148 |
CA |
25 | 2 |
Injection site erythema, Injection site inflammation, Injection site mass, |
||||
FREMANEZUMAB-VFRM, PROPRANOLOL HYDROCHLORIDE, TOPIRAMATE, |
||||
| 136 | 26528215 |
63 | ||
Psoriatic arthropathy, Abdominal pain, Candida infection, Injection site erythema, Dysphagia, Oropharyngeal discomfort, Eating disorder, Erythema, Skin discolouration, Injection site pain, Skin plaque, Weight decreased, Lichen planus, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, METOPROLOL TARTRATE, METOPROLOL, CETIRIZINE HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, SEMAGLUTIDE, ORAL SEMAGLUTIDE, ERGOCALCIFEROL, |
||||
| 137 | 26528269 |
US |
56 | 2 |
Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 138 | 26528736 |
US |
35 | 2 |
Injection site rash, Injection site erythema, |
||||
| 139 | 26529733 |
US |
31 | 2 |
Injection site erythema, Injection site irritation, Injection site haemorrhage, Device issue, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
| 140 | 26530104 |
51 | 1 | |
Limb discomfort, Injection site erythema, Injection site pruritus, Injection site swelling, Insomnia, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 141 | 26530110 |
28 | 2 | |
Nausea, Pruritus, Insomnia, Injection site pain, Injection site erythema, Injection site rash, Injection site swelling, Injection site pruritus, Injection site bruising, |
||||
REPOSITORY CORTICOTROPIN, |
||||
| 142 | 26530521 |
2 | ||
Injection site pruritus, Injection site erythema, Injection site swelling, Injection site mass, Injection site bruising, Malaise, |
||||
REPOSITORY CORTICOTROPIN, REPOSITORY CORTICOTROPIN, ADALIMUMAB, |
||||
| 143 | 26530527 |
44 | 2 | |
Cellulitis, Injection site urticaria, Injection site warmth, Injection site swelling, Injection site pain, Diarrhoea, Headache, Injection site erythema, Injection site rash, Injection site pruritus, |
||||
REPOSITORY CORTICOTROPIN, CETIRIZINE HYDROCHLORIDE, MONTELUKAST SODIUM, MONTELUKAST, FAMOTIDINE, |
||||
| 144 | 26522607 |
US |
34 | 2 |
Injection site erythema, |
||||
GALCANEZUMAB-GNLM, LAMOTRIGINE, |
||||
| 145 | 26523048 |
US |
68 | 2 |
Headache, Injection site erythema, Injection site rash, Injection site pruritus, Weight increased, Off label use, Drug ineffective, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 146 | 26523116 |
US |
67 | 2 |
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 147 | 26523120 |
US |
45 | 2 |
Injection site erythema, Injection site pruritus, |
||||
TIRZEPATIDE, |
||||
| 148 | 26523469 |
US |
71 | 2 |
Allodynia, Hunger, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 149 | 26523640 |
JP |
64 | 1 |
Skin plaque, Injection site erythema, Injection site swelling, Burning sensation, Epidermal necrosis, Skin hyperpigmentation, |
||||
DOCETAXEL, DOCETAXEL ANHYDROUS, DOCETAXEL, DOCETAXEL ANHYDROUS, LEUPROLIDE ACETATE, BICALUTAMIDE, |
||||
| 150 | 26523750 |
US |
33 | 2 |
Injection site erythema, Injection site swelling, Injection site induration, Fibromyalgia, |
||||
IXEKIZUMAB, |
||||
| 151 | 26524346 |
GB |
2 | |
Hospitalisation, Injection site mass, Injection site erythema, Injection site pain, Injection site indentation, Drug ineffective, Product dose omission issue, |
||||
GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, GLATIRAMER ACETATE, GLATIRAMER ACETATE INJECTION, GLATIRAMER, |
||||
| 152 | 26524477 |
US |
65 | 2 |
Nausea, Diarrhoea, Injection site erythema, Injection site mass, Injection site pruritus, Injection site pain, |
||||
TIRZEPATIDE, |
||||
| 153 | 26524581 |
US |
||
Injection site swelling, Injection site erythema, Injection site warmth, Nausea, Dizziness, |
||||
ICATIBANT, |
||||
| 154 | 26521997 |
US |
2 | |
Injection site pain, Injection site pruritus, Injection site erythema, Cough, |
||||
DUPILUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, DOXAZOSIN MESYLATE, DOXAZOSIN, HYDROCHLOROTHIAZIDE, ROSUVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, DENOSUMAB, ERGOCALCIFEROL, ALBUTEROL SULFATE, AZELASTINE HYDROCHLORIDE, AZELASTINE, LOSARTAN POTASSIUM, |
||||
| 155 | 26522006 |
US |
89 | 2 |
Injection site reaction, Injection site oedema, Injection site erythema, Injection site pruritus, |
||||
DUPILUMAB, |
||||
| 156 | 26522032 |
US |
55 | 2 |
Injection site erythema, Hypersensitivity, |
||||
TIRZEPATIDE, |
||||
| 157 | 26522087 |
US |
2 | |
Injection site pruritus, Injection site erythema, |
||||
SARILUMAB, |
||||
| 158 | 26522214 |
US |
66 | 2 |
Injection site swelling, Injection site warmth, Injection site erythema, Injection site pruritus, |
||||
SARILUMAB, |
||||
| 159 | 26525075 |
33 | 1 | |
Injection site pain, Gait disturbance, Movement disorder, Sensory disturbance, Injection site erythema, Nonspecific reaction, |
||||
LENACAPAVIR SODIUM, MINOXIDIL, DUTASTERIDE, BIOTIN, |
||||
| 160 | 26521296 |
US |
74 | 2 |
Incorrect dose administered, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 161 | 26521563 |
US |
56 | 1 |
Injection site erythema, Injection site irritation, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 162 | 26521810 |
US |
44 | 2 |
Scar, Injection site warmth, Injection site discomfort, Injection site pruritus, Injection site erythema, Injection site swelling, Drug hypersensitivity, |
||||
DUPILUMAB, OMEPRAZOLE, OMEPRAZOLE MAGNESIUM, ATENOLOL, |
||||
| 163 | 26521911 |
US |
52 | 2 |
Injection site swelling, Injection site pain, Injection site erythema, |
||||
SARILUMAB, ABATACEPT, |
||||
| 164 | 26516930 |
US |
68 | 1 |
Cardiac aneurysm, Injection site erythema, Product dose omission issue, |
||||
TIRZEPATIDE, |
||||
| 165 | 26517428 |
US |
73 | 1 |
Nephrolithiasis, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 166 | 26517437 |
US |
57 | 2 |
Overdose, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 167 | 26517681 |
56 | ||
Erythema, Pruritus, Skin burning sensation, Injection site erythema, Injection site swelling, Off label use, |
||||
BIMEKIZUMAB, BIMEKIZUMAB, BIMEKIZUMAB, |
||||
| 168 | 26518091 |
US |
56 | 2 |
Nasopharyngitis, Drug ineffective, Psoriasis, Injection site erythema, Injection site pruritus, |
||||
IXEKIZUMAB, IXEKIZUMAB, |
||||
| 169 | 26518458 |
40 | ||
Injection site erythema, |
||||
OLEZARSEN SODIUM, |
||||
| 170 | 26518480 |
|||
Injection site erythema, Injection site pain, |
||||
OLEZARSEN SODIUM, |
||||
| 171 | 26520562 |
56 | ||
Skin disorder, Injection site reaction, Illness, Infection, Injection site pain, Injection site erythema, Injection site rash, Injection site swelling, Injection site bruising, Injection site pruritus, |
||||
BIMEKIZUMAB, |
||||
| 172 | 26520803 |
US |
77 | 2 |
Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 173 | 26512261 |
|||
Injection site pruritus, Injection site erythema, Injection site reaction, Injection site pain, |
||||
BIMEKIZUMAB, AMITRIPTYLINE HYDROCHLORIDE, AMLODIPINE BESYLATE, CALCIUM, CELECOXIB, COLCHICINE, ESTRADIOL, ESTRADIOL GEL 0.1%, ESTRADIOL TRANSDERMAL, ESTRADIOL,, LEFLUNOMIDE, METHOTREXATE, METHOTREXATE SODIUM, OMEPRAZOLE MAGNESIUM, ERGOCALCIFEROL, ZINC, ZINC GLUCONATE, ZINC CHLORIDE, |
||||
| 174 | 26512319 |
US |
60 | 2 |
Pruritus, Injection site erythema, Swelling, |
||||
ABATACEPT, |
||||
| 175 | 26512337 |
|||
Injection site erythema, Injection site swelling, Injection site irritation, |
||||
CERTOLIZUMAB PEGOL, |
||||
| 176 | 26512548 |
US |
50 | 2 |
Erythema, Skin irritation, Injection site pruritus, Injection site erythema, Injection site vesicles, Injection site urticaria, Injection site pain, Injection site discharge, |
||||
TIRZEPATIDE, TIRZEPATIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 177 | 26512613 |
US |
63 | 1 |
Haemoglobin decreased, Eosinophil count increased, Blister, Injection site erythema, Injection site pain, Injection site haemorrhage, |
||||
TRALOKINUMAB-LDRM, TRALOKINUMAB-LDRM, |
||||
| 178 | 26512843 |
US |
2 | |
Injection site pruritus, Injection site erythema, Injection site rash, Injection site inflammation, Injection site reaction, |
||||
IRON DEXTRAN, |
||||
| 179 | 26512853 |
US |
62 | 2 |
Injection site mass, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 180 | 26512899 |
|||
Injection site pain, Injection site erythema, Drug ineffective, |
||||
CERTOLIZUMAB PEGOL, BACLOFEN, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, SERTRALINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, |
||||
| 181 | 26514297 |
US |
72 | 1 |
Diabetes mellitus inadequate control, Fall, Dizziness, Urinary tract infection, Dysuria, Urine flow decreased, White blood cell count increased, Contusion, Haemoglobin decreased, Blood cholesterol increased, Injection site erythema, |
||||
DUPILUMAB, |
||||
| 182 | 26514414 |
46 | 1 | |
Injection site rash, Injection site erythema, |
||||
TIRZEPATIDE, |
||||
| 183 | 26514529 |
US |
56 | 2 |
Incorrect dose administered, Injection site rash, Injection site erythema, |
||||
TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, TIRZEPATIDE, |
||||
| 184 | 26514547 |
GB |
1 | 1 |
Rash papular, Injection site swelling, Erythema, Injection site warmth, Pyrexia, Eczema, Injection site erythema, |
||||
| 185 | 26514741 |
US |
52 | 2 |
Multiple sclerosis relapse, Injection site erythema, Influenza like illness, |
||||
DALFAMPRIDINE, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, TIZANIDINE HYDROCHLORIDE, CARBOXYMETHYLCELLULOSE SODIUM, BACLOFEN, MAGNESIUM, FUROSEMIDE, POTASSIUM CHLORIDE, POTASSIUM CHLORIDE EXTENDED-RELEASE, POTASSIUM CHLORIDE, DEXTROSE MONOHYDRATE, POTASSIUM CHLORIDE ORAL, ERGOCALCIFEROL, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, HYDROCHLOROTHIAZIDE, INTERFERON BETA-1A, |
||||
| 186 | 26514849 |
US |
||
Injection site reaction, Injection site erythema, Injection site pruritus, |
||||
BUPRENORPHINE, BUPRENORPHINE, BUPRENORPHINE, |
||||
| 187 | 26515033 |
US |
29 | 2 |
Injection site erythema, Injection site swelling, Maternal exposure during pregnancy, |
||||
BUPRENORPHINE, METOCLOPRAMIDE HYDROCHLORIDE, |
||||
| 188 | 26515045 |
US |
62 | 2 |
Constipation, Injection site pruritus, Injection site rash, Injection site erythema, Injection site swelling, |
||||
TIRZEPATIDE, |
||||
| 189 | 26515110 |
US |
1 | |
Injection site mass, Injection site erythema, Injection site pain, |
||||
BUPRENORPHINE, |
||||
| 190 | 26515399 |
US |
1 | |
Injection site erythema, Injection site rash, |
||||
| 191 | 26515782 |
61 | ||
Injection site erythema, Injection site swelling, Injection site discolouration, |
||||
OLEZARSEN SODIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, CYCLOBENZAPRINE, DULOXETINE HYDROCHLORIDE, DULOXETINE, EZETIMIBE, FLUTICASONE PROPIONATE, ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CREAM 1%, ANTI-PRURITIC, HYDROCORTISONE CONTINUOUS SPRAY, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LORAZEPAM, MAGNESIUM OXIDE, METOPROLOL TARTRATE, METOROPROLOL TARTRATE, METOPROLOL, MOMETASONE, MULTIVITAMIN/MINERAL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, PITAVASTATIN CALCIUM, PITAVASTATIN, CLOPIDOGREL, EVOLOCUMAB, DESOXIMETASONE, GABAPENTIN, BRIMONIDINE TARTRATE, |
||||
| 192 | 26516268 |
US |
64 | 2 |
Heart rate increased, Alopecia, Nausea, Eructation, Injection site erythema, Injection site swelling, Injection site pruritus, Injection site urticaria, |
||||
TIRZEPATIDE, TIRZEPATIDE, |
||||
| 193 | 26516279 |
GB |
58 | 2 |
Injection site erythema, Injection site pruritus, Injection site swelling, |
||||
CIPROFLOXACIN, CIPROFLOXACIN HYDROCHLORIDE, CIPROFOLXACIN, CIPROFLOXACIN TABLETS, NITROFURANTOIN, NITROFURANTOIN (MONOHYDRATE/MACROCRYSTALS), |
||||
| 194 | 26516339 |
US |
21 | 2 |
Injection site reaction, Injection site erythema, Injection site pain, Injection site swelling, Injection site bruising, Injection site induration, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, FAMOTIDINE, LORATADINE, LORATADINE ORAL, |
||||
| 195 | 26508306 |
US |
69 | 2 |
Injection site swelling, Injection site erythema, Injection site pain, Injection site mass, Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 196 | 26508369 |
US |
70 | 2 |
Injection site pruritus, Injection site erythema, Injection site rash, |
||||
TIRZEPATIDE, |
||||
| 197 | 26508553 |
GB |
37 | 2 |
Ankylosing spondylitis, Tension, Injection site erythema, |
||||
ETANERCEPT, |
||||
| 198 | 26508896 |
US |
37 | 2 |
Injection site erythema, Injection site pain, |
||||
GALCANEZUMAB-GNLM, GALCANEZUMAB-GNLM, |
||||
| 199 | 26508942 |
IN |
40 | 2 |
Kounis syndrome, Injection site erythema, |
||||
DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 200 | 26509148 |
US |
63 | 1 |
Injection site urticaria, Injection site erythema, Injection site pain, Injection site pruritus, |
||||
INSULIN LISPRO-AABC, INSULIN ASPART, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2026-04-28